Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Liver Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2019 provides an overview of Liver Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Liver Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Liver Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Liver Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Liver Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


  • Introduction
    • Liver Cancer Diagnostic Tests Overview
  • Products under Development
    • Liver Cancer Diagnostic Tests - Pipeline Products by Stage of under Development
      • Table Figure 1: Liver Cancer Diagnostic Tests - Pipeline Products by Stage of under Development
      • Table Liver Cancer Diagnostic Tests - Pipeline Products by Stage of under Development
    • Liver Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Figure 2: Liver Cancer Diagnostic Tests - Pipeline Products by Territory
      • Table Liver Cancer Diagnostic Tests - Pipeline Products by Territory
    • Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Figure 3: Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
      • Table Liver Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
    • Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Figure 4: Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
      • Table Liver Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
    • Liver Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Figure 5: Liver Cancer Diagnostic Tests - Ongoing Clinical Trials
      • Table Liver Cancer Diagnostic Tests - Ongoing Clinical Trials
  • Liver Cancer Diagnostic Tests - Pipeline Products under Development by Companies
    • Liver Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
      • Table Liver Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
    • Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
      • Table Liver Cancer Diagnostic Tests - Pipeline Products by Stage of Development
  • Liver Cancer Diagnostic Tests Companies and Product Overview
    • Abbott Diagnostics Company Overview
      • Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abbott Diagnostics Pipeline Products & Ongoing Clinical Trials Overview
        • Table ARCHITECT c16000 System - PIVKA Assay - Product Status
        • Table ARCHITECT c16000 System - PIVKA Assay - Product Description
        • Table ARCHITECT c4000 System - PIVKA Assay - Product Status
        • Table ARCHITECT c4000 System - PIVKA Assay - Product Description
        • Table ARCHITECT c8000 System - PIVKA Assay - Product Status
        • Table ARCHITECT c8000 System - PIVKA Assay - Product Description
        • Table ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Status
        • Table ARCHITECT ci16200 Integrated System - PIVKA Assay - Product Description
        • Table ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Status
        • Table ARCHITECT ci4100 Integrated System - PIVKA Assay - Product Description
        • Table ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Status
        • Table ARCHITECT ci8200 Integrated System - PIVKA Assay - Product Description
        • Table ARCHITECT i4000SR System - PIVKA II Assay - Product Status
        • Table ARCHITECT i4000SR System - PIVKA II Assay - Product Description
    • Abcodia Ltd Company Overview
      • Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Abcodia Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - Liver Cancer Diagnostic Tests - Product Status
        • Table Biomarker Test - Liver Cancer Diagnostic Tests - Product Description
    • AXO Science SAS Company Overview
      • AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table AXO Science SAS Pipeline Products & Ongoing Clinical Trials Overview
        • Table Multiplexed Detection - Des-Carboxy Prothrombin - Product Status
        • Table Multiplexed Detection - Des-Carboxy Prothrombin - Product Description
        • Table Multiplexed Detection - Matrix metalloproteinase 1 - Product Status
        • Table Multiplexed Detection - Matrix metalloproteinase 1 - Product Description
        • Table Multiplexed Detection - Procollagen type III N-terminal peptide - Product Status
        • Table Multiplexed Detection - Procollagen type III N-terminal peptide - Product Description
    • BioMark Technologies Inc Company Overview
      • BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BioMark Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Assay - Hepatocellular Cancer - Product Status
        • Table Biomarker Assay - Hepatocellular Cancer - Product Description
    • Bioprognos SL Company Overview
      • Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table MBDAA Liver Cancer Test - Product Status
        • Table MBDAA Liver Cancer Test - Product Description
    • China Sky One Medical Inc Company Overview
      • China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Kit - Liver Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Kit - Liver Cancer Diagnostic Tests - Product Description
    • Digna Biotech SL Company Overview
      • Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table Digna Biotech SL Pipeline Products & Ongoing Clinical Trials Overview
        • Table HCC Molecular Marker Assay - Product Status
        • Table HCC Molecular Marker Assay - Product Description
        • Table Oxidated APO-A1 Assay - Product Status
        • Table Oxidated APO-A1 Assay - Product Description
    • Exact Sciences Corp Company Overview
      • Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Exact Sciences Corp Pipeline Products & Ongoing Clinical Trials Overview
        • Table Blood-based Liver Cancer Test - Product Status
        • Table Blood-based Liver Cancer Test - Product Description
        • Table DNA Biomarkers - Hepatocellular Carcinoma - Product Status
        • Table DNA Biomarkers - Hepatocellular Carcinoma - Product Description
    • Fujirebio Diagnostics Inc Company Overview
      • Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Lumipulse G - PIVKA-II Assay - Product Status
        • Table Lumipulse G - PIVKA-II Assay - Product Description
    • German Cancer Research Center Company Overview
      • German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table German Cancer Research Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table RAGE Based Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Status
        • Table RAGE Based Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Description
    • Glycotest Inc Company Overview
      • Glycotest Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glycotest Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table HCC Panel - Product Status
        • Table HCC Panel - Product Description
        • Table Glycotest Inc - Ongoing Clinical Trials Overview
        • Table HCC Panel - Case-control Study of the Glycotest HCC Panel Versus AFP for the Detection of Earlystage Hepatocellular Carcinoma
    • ImCare Biotech LLC Company Overview
      • ImCare Biotech LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table ImCare Biotech LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table HepatoDetect Diagnostic Kit - Product Status
        • Table HepatoDetect Diagnostic Kit - Product Description
    • Imperial College London Company Overview
      • Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Imperial College London Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - HCC - Product Status
        • Table Diagnostic Assay - HCC - Product Description
    • IntegraGen SA Company Overview
      • IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table IntegraGen SA Pipeline Products & Ongoing Clinical Trials Overview
        • Table IntegraGen SA Diagnostic Test - Hepatocellular Carcinoma - Product Status
        • Table IntegraGen SA Diagnostic Test - Hepatocellular Carcinoma - Product Description
    • Matrix-Bio Inc Company Overview
      • Matrix-Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Matrix-Bio Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table VeraMarker LCS (Liver Cancer Screening) Test - Product Status
        • Table VeraMarker LCS (Liver Cancer Screening) Test - Product Description
        • Table VeraMarker Liver Cancer Screening Test - Hepatitis - Product Status
        • Table VeraMarker Liver Cancer Screening Test - Hepatitis - Product Description
    • MDNA Life Sciences Inc Company Overview
      • MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table MDNA Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Mitomic Test - Liver Cancer Diagnostic Tests - Product Status
        • Table Mitomic Test - Liver Cancer Diagnostic Tests - Product Description
    • Medical University of South Carolina Company Overview
      • Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medical University of South Carolina Pipeline Products & Ongoing Clinical Trials Overview
        • Table Glycan-Based Biomarker Assay - Liver Cancer Diagnostic Tests - Product Status
        • Table Glycan-Based Biomarker Assay - Liver Cancer Diagnostic Tests - Product Description
    • Medical University of Vienna Company Overview
      • Medical University of Vienna Pipeline Products & Ongoing Clinical Trials Overview
        • Table Medical University of Vienna Pipeline Products & Ongoing Clinical Trials Overview
        • Table sAXL Biomarker Test - Hepatocellular Carcinoma - Product Status
        • Table sAXL Biomarker Test - Hepatocellular Carcinoma - Product Description
    • Memorial Sloan Kettering Cancer Center Company Overview
      • Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Memorial Sloan Kettering Cancer Center Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - Hepatocellular Carcinoma - Product Status
        • Table Biomarker Test - Hepatocellular Carcinoma - Product Description
    • NanoString Technologies Inc Company Overview
      • NanoString Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table NanoString Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table In Vitro Diagnostic Assay - HCC Gene Signature - Product Status
        • Table In Vitro Diagnostic Assay - HCC Gene Signature - Product Description
    • Numares AG Company Overview
      • Numares AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Numares AG Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Liver Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Test - Liver Cancer Diagnostic Tests - Product Description
    • Oncimmune (USA) LLC Company Overview
      • Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Oncimmune (USA) LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table EarlyCDT - Liver Cancer Kit - Product Status
        • Table EarlyCDT - Liver Cancer Kit - Product Description
    • Orion Genomics LLC Company Overview
      • Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orion Genomics LLC Pipeline Products & Ongoing Clinical Trials Overview
        • Table Orion Genomics LLC Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Status
        • Table Orion Genomics LLC Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Description
    • PleX Diagnostics Inc (Inactive) Company Overview
      • PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table PleX Diagnostics Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
        • Table HCCpleX - Product Status
        • Table HCCpleX - Product Description
    • ProMIS Neurosciences Inc Company Overview
      • ProMIS Neurosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table ProMIS Neurosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Screening Test - Liver Cancer Diagnostic Tests - Product Status
        • Table Screening Test - Liver Cancer Diagnostic Tests - Product Description
    • Proplex Technologies Llc Company Overview
      • Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proplex Technologies Llc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Diagnostic Test - Liver Cancer Diagnostic Tests - Product Status
        • Table Biomarker Diagnostic Test - Liver Cancer Diagnostic Tests - Product Description
    • Proteome Sciences Plc Company Overview
      • Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Proteome Sciences Plc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Assay - Liver Cancer Diagnostic Tests - Product Status
        • Table Biomarker Assay - Liver Cancer Diagnostic Tests - Product Description
    • Roche Diagnostics International Ltd Company Overview
      • Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview
        • Table Cobas 8000 Analyzer Series With e 801 Module - PIVKA Assay - Product Status
        • Table Cobas 8000 Analyzer Series With e 801 Module - PIVKA Assay - Product Description
    • University of Louisville Company Overview
      • University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Test - Hepatocellular Carcinoma - Product Status
        • Table Diagnostic Test - Hepatocellular Carcinoma - Product Description
    • University of Rochester Company Overview
      • University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
        • Table University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
        • Table Biomarker Test - HCC - Product Status
        • Table Biomarker Test - HCC - Product Description
    • Ventana Medical Systems Inc Company Overview
      • Ventana Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ventana Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
        • Table BLU-554 Companion Diagnostic Assay - Hepatocellular Carcinoma - Product Status
        • Table BLU-554 Companion Diagnostic Assay - Hepatocellular Carcinoma - Product Description
    • Viomics Inc. Company Overview
      • Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Viomics Inc. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Status
        • Table Diagnostic Assay - Liver Cancer Diagnostic Tests - Product Description
    • XEPTAGEN SpA Company Overview
      • XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table XEPTAGEN SpA Pipeline Products & Ongoing Clinical Trials Overview
        • Table DCP-IgM Kit - Liver Cancer Diagnostic Tests - Product Status
        • Table DCP-IgM Kit - Liver Cancer Diagnostic Tests - Product Description
        • Table GPC3-IgM Kit - Liver Cancer Diagnostic Tests - Product Status
        • Table GPC3-IgM Kit - Liver Cancer Diagnostic Tests - Product Description
        • Table Osteopontin-IgM Kit - Liver Cancer Diagnostic Tests - Product Status
        • Table Osteopontin-IgM Kit - Liver Cancer Diagnostic Tests - Product Description
        • Table Survivin-IgM Kit - Liver Cancer Diagnostic Tests - Product Status
        • Table Survivin-IgM Kit - Liver Cancer Diagnostic Tests - Product Description
        • Table VEGF-IgM Kit - Liver Cancer Diagnostic Tests - Product Status
        • Table VEGF-IgM Kit - Liver Cancer Diagnostic Tests - Product Description
    • Ymir Genomics LLC. Company Overview
      • Ymir Genomics LLC. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Ymir Genomics LLC. Pipeline Products & Ongoing Clinical Trials Overview
        • Table Diagnostic Assay - Hepatocellular Carcinoma - Product Status
        • Table Diagnostic Assay - Hepatocellular Carcinoma - Product Description
  • Liver Cancer Diagnostic Tests - Recent Developments
    • Nov 05, 2019: Blueprint Medicines outlines precision therapy research vision, provides update on discovery and clinical-stage portfolio at R&D Day and reports third quarter 2019 financial results
    • Oct 31, 2019: Proteome Sciences: Trading update and announcement of Board Changes
    • Oct 30, 2019: PerkinElmer announces financial results for the third quarter of 2019
    • Oct 29, 2019: Pfizer reports third-quarter 2019 results
    • Sep 27, 2019: Ian Read to retire as executive chairman of Pfizer's board of directors; chief executive Officer Dr. Albert Bourla named chairman
    • Sep 05, 2019: Simple CEUS Scan helps diagnose Liver Cancer when MRI is uncertain
    • Aug 27, 2019: ProMIS Neurosciences appoints Internationally Recognized Researcher in Alzheimer's Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board
    • Aug 21, 2019: PerkinElmer announces leadership succession plan
    • Aug 13, 2019: ProMIS Neurosciences announces second quarter 2019 results
    • Aug 08, 2019: Trovagene announces second quarter 2019 results and highlights
    • Aug 01, 2019: Blueprint Medicines reports second quarter 2019 financial results
    • Jul 30, 2019: Array Biopharma a subsidiary of Pfizer announces effective date of makewhole fundamental change and fundamental change company notice relating to its 2.625% convertible senior notes due 2024
    • Jul 29, 2019: Pfizer reports second-quarter 2019 results
    • Jul 29, 2019: PerkinElmer announces financial results for the second quarter of 2019
    • Jul 15, 2019: New biomarker-guided strategy has potential for liver cancer treatment
    • Jun 19, 2019: ProMIS Neurosciences appoints Renowned Parkinson's Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board
    • Jun 05, 2019: Jeff Settleman, Ph.D., joins Pfizer to lead oncology research & development
    • May 21, 2019: Verily forms strategic alliances with Novartis, Otsuka, Pfizer and Sanofi to transform clinical research
    • May 14, 2019: ProMIS Neurosciences announces first quarter 2019 results
    • May 09, 2019: Blueprint Medicines reports first quarter 2019 financial results
    • May 07, 2019: Trovagene announces first quarter 2019 results and highlights
    • May 02, 2019: Major life sciences and healthcare companies join Chronicled's MediLedger Project working group
    • Apr 30, 2019: Pfizer reports first-quarter 2019 results
    • Apr 25, 2019: PerkinElmer Announces Financial Results for the First Quarter of 2019
    • Mar 20, 2019: LAM to present data for cell-free DNA methylation assay for non-invasive diagnosis of liver, breast and colorectal cancers At AACR Annual Meeting 2019
    • Mar 18, 2019: Discovery of new biomarker for liver dysfunction following partial hepatectomy
    • Mar 15, 2019: ProMIS Neurosciences announces fiscal year 2018 annual results
    • Mar 11, 2019: Proton therapy increases survival rate of liver cancer patients
    • Mar 06, 2019: Trovagene announces fourth quarter and full-year 2018 results
    • Feb 26, 2019: Blueprint Medicines reports fourth quarter and full year 2018 financial results
    • Feb 21, 2019: ProMIS Neurosciences adds pharmaceutical leader Timothy Rothwell to board of advisors
    • Feb 01, 2019: Pfizer staff set to strike in dispute over pensions
    • Jan 31, 2019: PerkinElmer Announces Financial Results for the Fourth Quarter and Full Year 2018
    • Jan 24, 2019: Medochemie & Pfizer partner in Vietnam
    • Jan 23, 2019: Proteome Sciences: Year-end trading update
    • Jan 23, 2019: Up to 900 Pfizer staff to ballot for industrial action
    • Jan 08, 2019: Pfizer to exit two more plants in India
    • Dec 20, 2018: Oncimmune signs agreement with America's Choice Provider Network to expand access to its blood tests for the early detection of lung and liver cancers.
    • Dec 17, 2018: ProMIS Neurosciences appoints renowned neuroscientist, Dr. Rudolph Tanzi, to Scientific Advisory Board
    • Dec 10, 2018: PerkinElmer names Prahlad Singh as president & chief operating officer
    • Nov 19, 2018: Pfizer provides transparency on drug prices in the U.S; 90 percent of company's prices will remain unchanged
  • Appendix
    • Methodology
      • Table Glossary
    • About GlobalData
    • Contact Us
    • Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook